NEA
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Synthesia announces a £150m Series E led by Google Ventures to develop new conversational agents to support workplace learning
Synthesia creates AI-generated video tools for businesses, enabling organisations to produce training, learning and internal communications content using digital avatars and interactive, conversational video experiences.
CuspAI raises £75m Series A led by NEA and Temasek to accelerate AI-driven materials discovery
CuspAI applies generative AI and physics based simulation to design new materials, helping customers discover compounds faster for applications in energy, climate, computing and manufacturing.
Charm Therapeutics raises £60m Series B led by NEA and SR One to advance next generation cancer drug
Charm Therapeutics develops next generation cancer drugs designed to overcome treatment resistance, using an AI driven discovery platform to identify compounds for aggressive blood cancers such as AML.
Synthesia secures £150m in Series D funding led by NEA to advance AI video for enterprise communications
Synthesia develops enterprise video software that allows companies to create, localise and personalise video communications at scale, supporting internal training, product education and global knowledge sharing without traditional production costs.
More venture news
- 26 Jan 2026
SynthesiaSynthesia announces a £150m Series E led by Google Ventures to develop new conversational agents to support workplace learning
Series EAI - 15 Jan 2025
OwlstoneOwlstone raises £22m in the first close of its Series E round to advance its breath-based diagnostics device
Series ELife Sciences